We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+14.7%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$26.8B
AUM Growth
+$2.91B
(+12%)
Cap. Flow
+$381M
Cap. Flow
% of AUM
1.42%
Top 10 Holdings %
Top 10 Hldgs %
30.26%
Holding
2,338
New
416
Increased
946
Reduced
559
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$80.5M |
| 2 |
Netflix
NFLX
|
+$48M |
| 3 |
Broadcom
AVGO
|
+$47.1M |
| 4 |
Palantir
PLTR
|
+$44.5M |
| 5 |
Intuitive Surgical
ISRG
|
+$41.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$62.2M |
| 2 |
Global Payments
GPN
|
+$50.1M |
| 3 |
Honeywell
HON
|
+$31.1M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$30.5M |
| 5 |
Medtronic
MDT
|
+$30.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.25% |
| 2 | Financials | 14.66% |
| 3 | Consumer Discretionary | 9.77% |
| 4 | Communication Services | 9.36% |
| 5 | Healthcare | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Pitney Bowes
PBI
$2.42B
| $853K | ﹤0.01% |
78,200
| – | – |
|
977
Cohen & Steers
CNS
$4.18B
| $851K | ﹤0.01% |
11,300
+500
| +5% | +$38.4K |
|
978
Corcept Therapeutics
CORT
$10.2B
| $847K | ﹤0.01% |
11,540
-1,860
| -14% | -$135K |
|
979
SGHC Ltd
SGHC
$7.3B
| $847K | ﹤0.01% |
77,200
-16,400
| -18% | -$139K |
|
980
NCR Atleos
NATL
$3.52B
| $844K | ﹤0.01% |
29,600
+1,000
| +3% | +$27K |
|
|
PPBI
981
DELISTED
Pacific Premier Bancorp
PPBI
| $844K | ﹤0.01% |
40,000
+2,300
| +6% | +$47.8K |
|
982
Herc Holdings
HRI
$5.43B
| $843K | ﹤0.01% |
6,400
+600
| +10% | +$72.8K |
|
|
PINC
983
DELISTED
Premier
PINC
| $842K | ﹤0.01% |
+38,400
| New | +$827K |
|
984
Ligand Pharmaceuticals
LGND
$6.02B
| $841K | ﹤0.01% |
7,400
-100
| -1% | -$10.7K |
|
985
Perdoceo Education
PRDO
$1.9B
| $840K | ﹤0.01% |
25,700
-3,400
| -12% | -$101K |
|
986
Adaptive Biotechnologies
ADPT
$3.56B
| $836K | ﹤0.01% |
71,800
-10,500
| -13% | -$95.4K |
|
987
Phillips Edison & Co
PECO
$5.48B
| $834K | ﹤0.01% |
23,800
+800
| +3% | +$28.3K |
|
988
iRhythm Holdings
IRTC
$3.59B
| $831K | ﹤0.01% |
5,400
+4,000
| +286% | +$517K |
|
989
Vericel Corp
VCEL
$2.3B
| $830K | ﹤0.01% |
19,500
+1,300
| +7% | +$54.1K |
|
990
Indivior Pharmaceuticals
INDV
$4.79B
| $828K | ﹤0.01% |
+56,200
| New | +$655K |
|
991
Tecnoglass
TGLS
$2.01B
| $828K | ﹤0.01% |
10,700
+6,800
| +174% | +$527K |
|
992
AeroVironment
AVAV
$7.57B
| $826K | ﹤0.01% |
2,900
+1,300
| +81% | +$220K |
|
993
NovoCure
NVCR
$2.04B
| $826K | ﹤0.01% |
46,400
+3,800
| +9% | +$66.2K |
|
994
Bank of N.T. Butterfield & Son
NTB
$2.42B
| $824K | ﹤0.01% |
18,600
-300
| -2% | -$12.3K |
|
995
Sabra Healthcare REIT
SBRA
$5.64B
| $821K | ﹤0.01% |
44,500
| – | – |
|
996
Payoneer
PAYO
$2.41B
| $819K | ﹤0.01% |
119,500
+8,400
| +8% | +$56.9K |
|
997
Constellium
CSTM
$3.96B
| $817K | ﹤0.01% |
61,400
| – | – |
|
998
Patterson-UTI
PTEN
$3.87B
| $815K | ﹤0.01% |
137,500
+9,700
| +8% | +$58.4K |
|
999
ePlus
PLUS
$2.33B
| $815K | ﹤0.01% |
11,300
-600
| -5% | -$39.5K |
|
1000
Phinia Inc
PHIN
$2.9B
| $810K | ﹤0.01% |
18,200
+300
| +2% | +$12.7K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q2 2025 Portfolio in Review
As of Q2 2025, STRS Ohio held 2,338 positions worth $26.8B, up 12% from $23.9B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
STRS Ohio's Q2 2025 filing shows 416 new, 946 increased, 559 reduced and 143 closed positions. Its largest new stake was Rockwell Automation: 97,205 shares worth $32.3M. The largest sale was Progressive, an estimated $62.2M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
- STRS Ohio's largest Q2 2025 buy was Rockwell Automation: 97,205 shares worth $32.3M.
- STRS Ohio added most to Microsoft in Q2 2025, an estimated $80.5M increase.
- STRS Ohio's biggest Q2 2025 reduction was Progressive, cutting an estimated $62.2M.
- STRS Ohio fully exited AstraZeneca in Q2 2025, selling an estimated $26.8M.
- STRS Ohio's ten largest holdings make up 30% of its $26.8B portfolio in Q2 2025.
- STRS Ohio opened 416 new positions and closed 143 in Q2 2025.
- STRS Ohio's portfolio value rose 12% quarter-over-quarter to $26.8B.
Based on STRS Ohio's 13F filing for Q2 2025, filed 4 Aug 2025.